All In Biotech

Drug Trial Radar · NCT05101785

Articaine 4% Efficacy and Safety in Extraction and Pulpotomy of Primary Molars of Children Below the Age of Four Years

Articaine 4% Efficacy and Safety in Extraction and Pulpotomy of Primary Molars of Children Below the Age of Four Years.

Last checked: Nov 19, 2026Latest source record: Nov 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 292 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

292

Planned (sponsor's estimate)

Start

Nov 1, 2021

Primary completion

Sep 1, 2022

Study completion Nov 1, 2022

Sponsor

Lead sponsor
Mahmoud Ahmed MahmoudAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 1, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 3 years, up to 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

compare the anaesthetic efficacy and safety for pain and behaviour for extraction or pulp therapy in primary molars in young children below four years old using 4% articaine and 2% lidocaine local anesthetics.

Conditions

  • Pain
  • Behavior

Interventions

  • Lidocain hydrochloride 2 % with epinephrineDrug

    Local anesthesia infilteration in children

  • Articaine chloride 4% with epinephrineDrug

    Articaine chloride 4% with epinephrine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intra and post operative painTime frame: 30-60 minutes
  2. BehaviorTime frame: 30-60 minutes
  3. Blood pressureTime frame: 30-60 minutes
  4. Heart rateTime frame: 30-60 minutes
  5. Respiratory rate measuring during treatmentTime frame: 30-60 minutes

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.